Type 1 diabetes: fewer complications with intensive insulin therapy.
Extended follow-up of participants in the "DCCT" trial showed that, in type 1 diabetes, aiming for near-physiological blood glucose concentrations from the start of therapy reduces the risk of diabetic retinopathy, cardiovascular complications and renal impairment.